Workflow
金石亚药(300434.SZ)发布上半年业绩,归母净利润6574.54万元,增长67.71%
GOLDSTONE ASIA PHARM.GOLDSTONE ASIA PHARM.(SZ:300434) 智通财经网·2025-08-27 15:09

Core Viewpoint - Jinshi Yao (300434.SZ) reported a decrease in operating revenue for the first half of 2025, while net profit showed significant growth [1] Financial Performance - The company's operating revenue for the first half of 2025 was 492 million yuan, representing a year-on-year decrease of 5.80% [1] - Net profit attributable to shareholders was 65.74 million yuan, reflecting a year-on-year increase of 67.71% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 55.72 million yuan, which is a year-on-year increase of 50.45% [1] - Basic earnings per share were 0.1637 yuan [1]